| Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 CJL Murray, T Vos, R Lozano, M Naghavi, AD Flaxman, C Michaud, ... The lancet 380 (9859), 2197-2223, 2012 | 11589 | 2012 |
| Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 T Vos, AD Flaxman, M Naghavi, R Lozano, C Michaud, M Ezzati, ... The lancet 380 (9859), 2163-2196, 2012 | 10644 | 2012 |
| Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active‐surveillance report JJ Gómez‐Reino, L Carmona, VR Valverde, EM Mola, MD Montero Arthritis & Rheumatism: Official Journal of the American College of …, 2003 | 1336 | 2003 |
| The global burden of rheumatoid arthritis: estimates from the global burden of disease 2010 study M Cross, E Smith, D Hoy, L Carmona, F Wolfe, T Vos, B Williams, ... Annals of the rheumatic diseases 73 (7), 1316-1322, 2014 | 1332 | 2014 |
| Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry M Gianfrancesco, KL Hyrich, S Al-Adely, L Carmona, MI Danila, L Gossec, ... Annals of the rheumatic diseases 79 (7), 859-866, 2020 | 1219 | 2020 |
| The burden of musculoskeletal diseases in the general population of Spain: results from a national survey L Carmona, J Ballina, R Gabriel, A Laffon Annals of the rheumatic diseases 60 (11), 1040-1045, 2001 | 1125 | 2001 |
| Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists L Carmona, JJ Gómez‐Reino, V Rodríguez‐Valverde, D Montero, ... Arthritis & Rheumatism 52 (6), 1766-1772, 2005 | 821 | 2005 |
| Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry A Strangfeld, M Schäfer, MA Gianfrancesco, S Lawson-Tovey, JW Liew, ... Annals of the rheumatic diseases 80 (7), 930-942, 2021 | 677 | 2021 |
| Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research … K Visser, W Katchamart, E Loza, JA Martinez-Lopez, C Salliot, J Trudeau, ... Annals of the rheumatic diseases 68 (7), 1086-1093, 2009 | 675 | 2009 |
| EULAR recommendations for the management of familial Mediterranean fever S Ozen, E Demirkaya, B Erer, A Livneh, E Ben-Chetrit, G Giancane, ... Annals of the rheumatic diseases 75 (4), 644-651, 2016 | 604 | 2016 |
| The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement I Solovic, M Sester, JJ Gomez-Reino, HL Rieder, S Ehlers, HJ Milburn, ... European Respiratory Journal 36 (5), 1185-1206, 2010 | 602 | 2010 |
| Assessment of inflammatory activity in rheumatoid arthritis: a comparative study of clinical evaluation with grey scale and power Doppler ultrasonography E Naredo, G Bonilla, F Gamero, J Uson, L Carmona, A Laffon Annals of the rheumatic diseases 64 (3), 375-381, 2005 | 599 | 2005 |
| Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study COVIDSurg Collaborative Anaesthesia 76 (6), 748-758, 2021 | 585* | 2021 |
| Risk of tuberculosis in patients treated with tumor necrosis factor antagonists due to incomplete prevention of reactivation of latent infection JJ Gómez‐Reino, L Carmona, M Ángel Descalzo Arthritis Care & Research: Official Journal of the American College of …, 2007 | 527 | 2007 |
| 2018 update of the EULAR recommendations for the management of hand osteoarthritis M Kloppenburg, FPB Kroon, FJ Blanco, M Doherty, KS Dziedzic, ... Annals of the rheumatic diseases 78 (1), 16-24, 2019 | 521 | 2019 |
| European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies M Mosca, C Tani, M Aringer, S Bombardieri, D Boumpas, R Brey, ... Annals of the rheumatic diseases 69 (7), 1269-1274, 2010 | 516 | 2010 |
| Longitudinal power Doppler ultrasonographic assessment of joint inflammatory activity in early rheumatoid arthritis: predictive value in disease activity and radiologic progression E Naredo, P Collado, A Cruz, MJ Palop, F Cabero, P Richi, L Carmona, ... Arthritis Care & Research: Official Journal of the American College of …, 2007 | 495 | 2007 |
| The prevalence of rheumatoid arthritis in the general population of Spain L Carmona, V Villaverde, C Hernández‐García, J Ballina, R Gabriel, ... Rheumatology 41 (1), 88-95, 2002 | 468 | 2002 |
| Prevalence and impact of fibromyalgia on function and quality of life in individuals from the general population: results from a nationwide study in Spain AJ Mas, L Carmona, M Valverde, B Ribas Clinical & Experimental Rheumatology 26 (4), 519, 2008 | 431 | 2008 |
| Multinational evidence-based recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion of a broad panel of … F Sivera, M Andrés, L Carmona, ASR Kydd, J Moi, R Seth, ... Annals of the rheumatic diseases 73 (2), 328-335, 2014 | 408 | 2014 |